Capital Flow Monitor · Sponsors · CIK 1809726

Claris Biotherapeutics, Inc.

475 MAGELLAN AVE, HALF MOON BAY, CA, 94019 · 201-344-7638

Biotechnology · Corporation· inc. DELAWARE true

Fit score

—

Offering

$121.5M

Sold

$55.7M

% sold

45.9%

Investors

14

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-08-12 D/A ·current 506(b) $121.5M $55.7M 45.9% 14 EDGAR ↗
2026-08-07 D 506(b) $121.5M $55.7M 45.9% 14 EDGAR ↗
2025-09-22 D 506(b) $2.3M $2.3M 100.0% 6 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Stephen Brady — Executive Officer / Director, Half Moon Bay, CA
    1 other raise
  • Reza Dana — Director, Half Moon Bay, CA
    2 other raises
  • Kenneth Harrison — Director, Half Moon Bay, CA
  • Marc de Garidel — Director, Half Moon Bay, CA
  • Meredith Fisher — Director, Half Moon Bay, CA
  • Henry Rath — Executive Officer, Half Moon Bay, CA
  • Susan Orr — Executive Officer, Half Moon Bay, CA
  • Michael Dybbs — Director, Half Moon Bay, CA
    3 other raises
  • Matt Hobson — Director, Half Moon Bay, CA
  • Maha Radhakrishnan — Director, Half Moon Bay, CA
  • Clarke Atwell — Executive Officer, Half Moon Bay, CA
  • Brian Baum — Executive Officer, Half Moon Bay, CA
    1 other raise

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.